These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3987496)

  • 21. Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction.
    Schulz-Key S; Carlsson JO; Crafoord S
    Acta Ophthalmol; 2011 Mar; 89(2):159-65. PubMed ID: 19860781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
    Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
    Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein AI-Derived Vitreous Amyloidosis: An Elusive Diagnosis.
    Yepez JB; Murati FA; Petitto M; De Yepez J; Galue JM; Vinardell S; Mura M; Arevalo JF
    Case Rep Ophthalmol; 2020; 11(2):287-292. PubMed ID: 32774294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg.
    Long D; Zeng J; Wu LQ; Tang LS; Wang HL; Wang H
    Ophthalmic Genet; 2012 Mar; 33(1):28-33. PubMed ID: 21843040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Needle-shaped deposits on retinal surface in a case of ocular amyloidosis.
    Hattori T; Shimada H; Yuzawa M; Kinukawa N; Fukuda T; Yasuda N
    Eur J Ophthalmol; 2008; 18(3):473-5. PubMed ID: 18465738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isolated vitreous amyloidosis].
    Vermuso L; Gueudry J; Sauvêtre G; Piton N; Guerrot AM; Sturtz F; Portmann A; Muraine M
    J Fr Ophtalmol; 2017 Jan; 40(1):e7-e9. PubMed ID: 28065461
    [No Abstract]   [Full Text] [Related]  

  • 27. A technique for facilitated visualization and dissection of the vitreous base, pars plana, and pars plicata.
    Murray TG; Boldt HC; Lewis H; Abrams GW; Mieler WF; Han DP
    Arch Ophthalmol; 1991 Oct; 109(10):1458-9. PubMed ID: 1929943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An unusual case of ocular involvement in primary systemic nonfamilial amyloidosis.
    Schwartz MF; Green WR; Michels RG; Kincaid MC; Fogle J
    Ophthalmology; 1982 Apr; 89(4):394-401. PubMed ID: 7099557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular amyloidosis.
    Priluck IA
    Nebr Med J; 1994 Feb; 79(2):25-7. PubMed ID: 8177350
    [No Abstract]   [Full Text] [Related]  

  • 30. SURGICAL REMOVAL OF DENSE POSTERIOR CAPSULE OPACIFICATION AND VITREOUS FLOATERS IN ADULTS BY POSTERIOR CONTINUOUS CURVILINEAR CAPSULORHEXIS THROUGH THE PARS PLANA AND 23-GAUGE VITRECTOMY.
    Lin J; Su Z; Huang X; Ji X; Yao K
    Retina; 2016 Nov; 36(11):2080-2086. PubMed ID: 27078801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitrectomy for large vitreous opacity in retinitis pigmentosa.
    Hong PH; Han DP; Burke JM; Wirostko WJ
    Am J Ophthalmol; 2001 Jan; 131(1):133-4. PubMed ID: 11162992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incarceration of asteroid bodies in sclerotomy wound following pars plana vitrectomy.
    Riffenburgh RS; Roth AM
    Ophthalmic Surg; 1984 Jan; 15(1):31-3. PubMed ID: 6700943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent amyloid involvement in the virreous body after vitrectomy.
    Irvine AR; Char DH
    Am J Ophthalmol; 1976 Nov; 82(5):705-8. PubMed ID: 998692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonfamilial vitreous amyloidosis diagnosed by portable sutureless vitrectomy.
    Shukla S; Cohen A; Josephberg RG
    Retin Cases Brief Rep; 2008; 2(4):264-5. PubMed ID: 25390585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pars plana vitrectomy. Vitrectomy treatment of vitreous opacities.
    Peyman GA; Huamonte FU; Goldberg MF
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(3 Pt 1):394-8. PubMed ID: 960361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of complications after cataract surgery by the pars plana approach.
    Pedersen OO
    Acta Ophthalmol (Copenh); 1983 Aug; 61(4):567-75. PubMed ID: 6605648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitreous amyloidosis as primary manifestation of disease: case report.
    García Franco R; Arias Gómez A; García Roa M; Ramírez Neria P; Corredor Casas S
    Arch Soc Esp Oftalmol (Engl Ed); 2020 May; 95(5):244-247. PubMed ID: 32145978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panretinal photocoagulation in the treatment of vitreoretinal amyloidosis.
    Baum MD; Weiss HS; Sanders RJ
    Arch Ophthalmol; 1998 Nov; 116(11):1534. PubMed ID: 9823364
    [No Abstract]   [Full Text] [Related]  

  • 39. Entoptic phenomenon following pars plana vitrectomy caused by retained preretinal gel.
    Yavuz GA; Unver YB; Sinclair SH
    Ophthalmic Surg Lasers Imaging; 2009; 40(2):188-91. PubMed ID: 19320311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratometric alterations following the 25-gauge transconjunctival sutureless pars plana vitrectomy versus the conventional pars plana vitrectomy.
    Citirik M; Batman C; Bicer T; Zilelioglu O
    Clin Exp Optom; 2009 Sep; 92(5):416-20. PubMed ID: 19549227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.